Literature DB >> 9075069

Idiopathic hyperplasia of the adrenal gland behaving like an aldosterone producing adenoma.

A Rao1, J C Melby.   

Abstract

Primary hyperaldosteronism (adrenal adenoma and idiopathic hyperplasia) is a disorder with hypertension, hypokalemia, elevated serum aldosterone and suppressed plasma renin activity. Hyperplasia is managed medically whereas adenomas are treated surgically. Selective adrenal venous catheterization and aldosterone measurement is a useful tool in making the distinction in 95% of cases. We report a case of bilateral idiopathic hyperplasia of the adrenal glands adequately treated with medications for 6 years followed by worsening. Selective catheterization was consistent with a right sided adenoma. Surgical removal of the right adrenal gland alleviated her symptoms. Pathological examination showed focal nodular hyperplasia. We propose that in the course of the disease the focal hyperplastic nodule became autonomous and behaved like an adenoma. Monitoring of patients with adrenal hyperplasia for recurrence of symptoms is prudent as surgery is beneficial in patients who develop an autonomous nodule.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9075069     DOI: 10.1007/BF03347969

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  14 in total

1.  [A case of primary aldosteronism due to unilateral multiple adrenal adenomas].

Authors:  H Fuse; I Mizuno; O Nagakawa; T Kazama; T Terada; T Katayama; S Masuda
Journal:  Hinyokika Kiyo       Date:  1990-07

2.  Primary aldosteronism: diagnosis, localization, and treatment.

Authors:  M H Weinberger; C E Grim; J W Hollifield; D C Kem; A Ganguly; N J Kramer; H Y Yune; H Wellman; J P Donohue
Journal:  Ann Intern Med       Date:  1979-03       Impact factor: 25.391

Review 3.  Diagnosis and treatment of primary aldosteronism and isolated hypoaldosteronism.

Authors:  J C Melby
Journal:  Clin Endocrinol Metab       Date:  1985-11

4.  Identification and implications of new types of mineralocorticoid hypertension.

Authors:  E G Biglieri; I Irony; C E Kater
Journal:  J Steroid Biochem       Date:  1989-01       Impact factor: 4.292

5.  Conn's syndrome due to adrenal hyperplasia with hypertrophy of zona glomerulosa, relieved by unilateral adrenalectomy.

Authors:  E J Ross
Journal:  Am J Med       Date:  1965-12       Impact factor: 4.965

6.  Diagnosis and localization of aldosterone-producing adenomas by adrenal-vein cateterization.

Authors:  J C Melby; R F Spark; S L Dale; R H Egdahl; P C Kahn
Journal:  N Engl J Med       Date:  1967-11-16       Impact factor: 91.245

Review 7.  Aldosterone-producing tumors (Conn's syndrome).

Authors:  R C Merrell
Journal:  Semin Surg Oncol       Date:  1990

8.  Primary aldosteronism due to unilateral adrenal hyperplasia.

Authors:  A Ganguly; P G Zager; J A Luetscher
Journal:  J Clin Endocrinol Metab       Date:  1980-11       Impact factor: 5.958

9.  Primary hyperaldosteronism in childhood due to unilateral macronodular hyperplasia. Case report.

Authors:  S E Oberfield; L S Levine; A Firpo; D Lawrence; E Stoner; D J Levy; S Sen; M I New
Journal:  Hypertension       Date:  1984 Jan-Feb       Impact factor: 10.190

Review 10.  Unilateral adrenal hyperplasia as a cause of primary aldosteronism.

Authors:  N V Dye; N J Litton; M Varma; W L Isley
Journal:  South Med J       Date:  1989-01       Impact factor: 0.954

View more
  2 in total

Review 1.  Primary hyperaldosteronism secondary to unilateral adrenal hyperplasia: an unusual cause of surgically correctable hypertension. A review of 30 cases.

Authors:  Brian K P Goh; Yeh-Hong Tan; Kenneth T E Chang; Peter H K Eng; Sidney K H Yip; Christopher W S Cheng
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

2.  Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism.

Authors:  Allison B Weisbrod; Richard C Webb; Aarti Mathur; Stephanie Barak; Smita Baid Abraham; Naris Nilubol; Martha Quezado; Constantine A Stratakis; Electron Kebebew
Journal:  Ann Surg Oncol       Date:  2012-10-23       Impact factor: 5.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.